Effects of Powered Hip Flexion Device in Persons With Multiple Sclerosis

Part of paid clinical trials in Dayton, Ohio.

Sponsor
University of Dayton
Study ID
NCT07724093
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Multiple Sclerosis (MS) Relapsing Remitting

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Powered Hip Flexion Orthosis (Hypershell X) — DEVICE
    Participants will perform a series of 10 meters walks while wearing the hip flexion assist device under the following conditions. 1) No assistance (passive mode) 2) 25% power assistance 3) 50% power assistance 4) 75% power assistance During the trial subjects will wear motion sensors that provide the following gait parameters: speed, step and stride length, foot clearance, foot angle at heel strike, circumduction, single and double support time.

Study Details

The purpose of this study is to assess the immediate effects of a commercially available non-FDA regulated powered hip flexion assist device (Hypershell X, Shenzhen, China) on walking ability in persons with MS. The main question it aims to answer is: Does a powered hip flexion device provide immediate improvements in walking ability over short distances for people with MS?

Key Dates

First listed
Jul 23, 2026
Start date
Jul 15, 2026
Status verified
Jul 2026
Primary completion
May 1, 2027
Completion
May 1, 2028

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Hip flexion assist
    Participants will perform a series of 10 meters walks while wearing the hip flexion assist device under the following conditions. 1. No assistance (passive mode) 2. 25% power assistance 3. 50% power assistance 4. 75% power assistance During the trial subjects will wear motion sensors that provide the following gait parameters: speed, step and stride length, foot clearance, foot angle at heel strike, circumduction, single and double support time.

Primary Outcome Measure

Gait speed [ Time Frame: Day 1 (immediate effect of device use) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of DaytonDaytonOhio45469
Kurt Jackson, PhD
[email protected]
937-229-5605

Find similar trials in Dayton, OH

By research site
University of Dayton· Dayton, OH